Related Experiment Video
Updated: Jun 25, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Current status of newer carbapenems
Matteo Bassetti1, Laura Nicolini, Silvano Esposito
1Infectious Diseases Division, San Martino University Hospital and University of Genoa, Genoa, Italy. matteo.bassetti@hsanmartino.it
Objectives:
Beta-lactam antibiotics represent the most commonly prescribed antibacterial agents. Since many bacteria have developed resistance to older agents, new beta-lactams have been introduced constantly. In the late 1970s, a new class of exceptionally broad-spectrum beta-lactams, the carbapenems, was identified. The carbapenems, such as the most popular imipenem and meropenem, have the widest spectra of antibacterial activity of all the beta-lactams and provide excellent coverage of many gram-negative and gram-positive aerobic and anaerobic bacteria. Despite the wide antibacterial spectrum, the carbapenems globally lack activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus (MRSA) and Stenotrophomonas maltophilia.
Methods:
We reviewed the principal characteristics of the novel carbapenems and their clinical implications.
Results And Conclusions:
We included in our review: ertapenem, biapenem, panipenem, doripenem, tebipenem pivoxil and tomopenem.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Inhibitors of Gram-positive Cell Wall Synthesis
Antibiotic Selection